Vivos Therapeutics Inc — Cash Flow (NASDAQ:VVOS) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -5.68 M-15.73 M-19.59 M-11.95 M-12.69 M -14.39 M Cash from investing activities -120.25 K-2.61 M-924 K-853 K-568 K -6.11 M Cash from financing activities 23.54 M24.17 M010.92 M17.88 M 17.28 M Free cash flow -5.8 M-18.13 M-20.51 M-12.75 M-13.26 M -15.37 M

Haberler

Vivos Therapeutics, Seneca ile 2,25 milyon dolarlık özel yerleştirmeyi kapattı

Vivos Therapeutics yatırımcısı 1,8 milyon dolarlık hisse aldı

Vivos Therapeutics Nevada’da sigorta ağı erişimi kazandı

NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Health Catalyst (HCAT) Lags Q4 Earnings Estimates

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivos Therapeutics (NASDAQ:VVOS)

Vivos Therapeutics 4,64 milyon dolarlık hisse senedi alım hakkı anlaşmasını duyurdu

Vivos Therapeutics announces $4.64 million warrant exercise deal

Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know

Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript